McKinsey's $650M Opioid Settlement Sends Warning to Consultants
TL;DR Summary
McKinsey has agreed to a $650 million settlement with the US Department of Justice over its role in advising opioid manufacturers, including Purdue Pharma, during the opioid crisis. The firm admitted to conspiring to misbrand prescription drugs and will face restrictions on future pharmaceutical consulting work. A former senior partner, Martin Elling, will plead guilty to obstructing justice by destroying documents. This marks the first criminal accountability for a consulting firm in such a case, highlighting the legal risks for consultants involved in client misconduct.
- Prosecutors label $650mn McKinsey opioid pact a warning to consultants Financial Times
- McKinsey to Pay $650 Million in Opioid Settlement With Justice Department The New York Times
- McKinsey & Company to pay $650 million for role in opioid crisis while executives avoid trials NPR
- Live news: Porsche SE sees up to €20bn write down of Volkswagen stake Financial Times
- McKinsey & Company agrees to pay $650M for helping Purdue Pharma boost opioid sales The Associated Press
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
3 min
vs 4 min read
Condensed
86%
623 → 85 words
Want the full story? Read the original article
Read on Financial Times